Thomas J. Lynch, Jr., MD, has been named director of Yale Cancer Center and physician-in-chief of the new Smilow Cancer Hospital at Yale-New Haven, which will open in October 2009. His appointment is effective April 1, 2009.Dr. Lynch, professor of medicine at Harvard Medical School, is chief of hematology/oncology at Massachusetts General Hospital (MGH) Cancer Center. A lung cancer expert, he is director of the Center for Thoracic Cancers at MGH and director of medical oncology at the MGH Thoracic Oncology Center.
Lynch also will oversee a new institute for cancer biology at Yale’s 136-acre West Campus, for which he will be recruiting a director and senior and junior scientists in the fields of cell signaling, cancer immunology and drug development and target acquisition.
Personalized cancer therapy uses molecular profiling to match therapy to the genetic signature of the patient’s tumor.
Other major plans for the new center include recruiting clinicians and translational researchers, expanding clinical trials and developing a clinical program that will provide molecular profiling services to enable targeted therapies.
